Epify

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Epignostix

This company develops AI-powered software for molecular tumour classification to help pathologists and clinicians provide precise cancer diagnoses and personalised treatment plans.

Epigenica

This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

Elphogene

This biotechnology company develops a molecular liquid biopsy test to monitor cancer progression and treatment efficacy for oncology patients and healthcare professionals.

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.